Bleakley Financial Group LLC Invests $2.91 Million in VanEck Biotech ETF $BBH

Bleakley Financial Group LLC purchased a new stake in shares of VanEck Biotech ETF (NASDAQ:BBH) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 18,980 shares of the company’s stock, valued at approximately $2,909,000. Bleakley Financial Group LLC owned 0.90% of VanEck Biotech ETF as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the business. Flagship Harbor Advisors LLC raised its holdings in shares of VanEck Biotech ETF by 9.8% in the 1st quarter. Flagship Harbor Advisors LLC now owns 2,179 shares of the company’s stock worth $343,000 after buying an additional 195 shares in the last quarter. Wealthfront Advisers LLC raised its position in shares of VanEck Biotech ETF by 25.1% during the first quarter. Wealthfront Advisers LLC now owns 7,252 shares of the company’s stock worth $1,141,000 after acquiring an additional 1,455 shares during the last quarter. Cetera Investment Advisers lifted its position in VanEck Biotech ETF by 15.8% during the 1st quarter. Cetera Investment Advisers now owns 3,094 shares of the company’s stock valued at $487,000 after purchasing an additional 423 shares during the period. Altfest L J & Co. Inc. boosted its stake in shares of VanEck Biotech ETF by 15.1% in the 1st quarter. Altfest L J & Co. Inc. now owns 7,661 shares of the company’s stock valued at $1,205,000 after purchasing an additional 1,007 shares during the last quarter. Finally, Simplex Trading LLC boosted its stake in VanEck Biotech ETF by 100.8% in the first quarter. Simplex Trading LLC now owns 474 shares of the company’s stock valued at $74,000 after acquiring an additional 238 shares during the last quarter. Institutional investors and hedge funds own 32.05% of the company’s stock.

VanEck Biotech ETF Stock Down 0.0%

Shares of VanEck Biotech ETF stock opened at $177.39 on Friday. VanEck Biotech ETF has a 12 month low of $135.34 and a 12 month high of $179.81. The business has a fifty day simple moving average of $169.09 and a 200 day simple moving average of $158.25.

VanEck Biotech ETF Company Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.